Bdh Industries Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of BDH Industries Ltd is ₹ 369.3 as of 06 May 15:30 . The P/E Ratio of BDH Industries Ltd changed from 8.6 on March 2021 to 16.3 on March 2025 . This represents a CAGR of 13.64% over 5 yearsThe P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of BDH Industries Ltd changed from ₹ 53.19 crore on March 2021 to ₹ 151.46 crore on March 2025 . This represents a CAGR of 23.28% over 5 yearsThe Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 years The revenue of BDH Industries Ltd for the Dec '25 is ₹ 29.87 crore as compare to the Sep '25 revenue of ₹ 19.51 crore. This represent the growth of 53.1% The revenue of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ 33.93 crore as compare to the Sep '25 revenue of ₹ 14.25 crore. This represent the growth of 138.11% The ebitda of BDH Industries Ltd for the Dec '25 is ₹ 4.76 crore as compare to the Sep '25 ebitda of ₹ 3.88 crore. This represent the growth of 22.68% The ebitda of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ -4.08 crore as compare to the Sep '25 ebitda of ₹ -4.63 crore. This represent the decline of -11.88% The net profit of BDH Industries Ltd changed from ₹ 1.57 crore to ₹ 3.49 crore over 7 quarters. This represents a CAGR of 57.85% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ -4.84 crore over 7 quarters. This represents a CAGR of 106.55% The Dividend Payout of BDH Industries Ltd changed from 28.02 % on March 2021 to 27.96 % on March 2025 . This represents a CAGR of -0.04% over 5 yearsThe Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About BDH Industries Ltd

Incorporated in 1990 as a private limited company, BDH Industries Limited (BDHIL) was converted into a public limited company in 1994.
It was established to takeover a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments. The Company is engaged in manufacturing of therapeutic formulations covering wide range of Pharmaceuticals and Renewable Energy segments.
BDH offers a full range of Oral Solid Dosages (OSD) technologies.
Research &Development Centre at Kandivali, Mumbai, undertake formulation development projects on new Novel Drug Delivery System (NDDS). It came out with a public issue in Feb.'95, aggregating Rs 6.

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

FAQs for the comparison of BDH Industries Ltd and Oxygenta Pharmaceutical Ltd

Which company has a larger market capitalization, BDH Industries Ltd or Oxygenta Pharmaceutical Ltd?

Market cap of BDH Industries Ltd is 212 Cr while Market cap of Oxygenta Pharmaceutical Ltd is 200 Cr

What are the key factors driving the stock performance of BDH Industries Ltd and Oxygenta Pharmaceutical Ltd?

The stock performance of BDH Industries Ltd and Oxygenta Pharmaceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for BDH Industries Ltd and Oxygenta Pharmaceutical Ltd?

As of May 6, 2026, the BDH Industries Ltd stock price is INR ₹369.3. On the other hand, Oxygenta Pharmaceutical Ltd stock price is INR ₹54.32.

How do dividend payouts of BDH Industries Ltd and Oxygenta Pharmaceutical Ltd compare?

To compare the dividend payouts of BDH Industries Ltd and Oxygenta Pharmaceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.